OPUS GENETICS INC. - COMMON STOCK
1.1800
01-11月-24 14:59:56
15 分の遅延
株式
-0.0200
-1.67%
本日の幅
1.1600 - 1.2185
ISIN
N/A
ソース
NASDAQ
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09 7 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire’s VEGA-1 Phase 2 Trial in Presbyopia Meets Primary and Secondary Endpoints
30 6 2021 06:15:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Announces Addition to the Russell Microcap® Index
11 6 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market
08 6 2021 15:10:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Announces Appointment of Jay S. Pepose, M.D., Ph.D. to Its Board of Directors
08 6 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
04 6 2021 08:04:27 提供 Nasdaq GlobeNewswire
-
20 5 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
18 5 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
12 5 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Announces Financial Results for the First Quarter 2021 and Provides Corporate Update
07 5 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
22 4 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy
08 4 2021 07:31:26 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 4 2021 16:10:53 提供 Nasdaq GlobeNewswire
-
15 3 2021 05:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Announces Financial Results for the Full Year 2020 and Provides Corporate Update
10 3 2021 15:30:00 提供 Nasdaq GlobeNewswire
-
05 3 2021 07:44:07 提供 Nasdaq GlobeNewswire
-
Ocuphire to Participate in March Investor Conferences
04 3 2021 07:27:09 提供 Nasdaq GlobeNewswire
-
Ocuphire Initiates Enrollment in VEGA-1 Phase 2 Trial Investigating Nyxol in Presbyopia
18 2 2021 07:53:31 提供 Nasdaq GlobeNewswire
-
11 2 2021 08:12:54 提供 Nasdaq GlobeNewswire
-
20 1 2021 06:00:00 提供 Nasdaq GlobeNewswire